{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:44:25Z","timestamp":1785001465534,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173517"],"award-info":[{"award-number":["81173517"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81322053"],"award-info":[{"award-number":["81322053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vph.2014.04.007","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:45:18Z","timestamp":1400201118000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism"],"prefix":"10.1016","volume":"62","author":[{"given":"Chen-Yuan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Min","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2014.04.007_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4614-5441-0_5","article-title":"Global prevalence and future of diabetes mellitus","volume":"771","author":"Ginter","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vph.2014.04.007_bb0010","first-page":"209538","article-title":"Vascular complications and diabetes: current therapies and future challenges","author":"Willard","year":"2012","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.vph.2014.04.007_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.amjmed.2009.09.020","article-title":"Diabetic retinopathy: an update on treatment","volume":"123","author":"Fantes","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.vph.2014.04.007_bb0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0974-9233.119993","article-title":"Evolving strategies in the management of diabetic retinopathy","volume":"20","author":"Abu EI-Asrar","year":"2013","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.vph.2014.04.007_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2014.04.007_bb0030","first-page":"106594","article-title":"Animal models of diabetic retinopathy: summary and comparison","author":"Lai","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.vph.2014.04.007_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/157339912798829188","article-title":"Diabetic retinopathy: current and new treatment options","volume":"8","author":"Giuliari","year":"2012","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.vph.2014.04.007_bb0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.vph.2014.04.007_bb0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/138920111794480525","article-title":"Anti-angiogenesis drugs in diabetic retinopathy","volume":"12","author":"Jeganathan","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.vph.2014.04.007_bb0050","first-page":"728325","article-title":"The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment","author":"Tremolada","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.vph.2014.04.007_bb0055","series-title":"Shi-Hu in China Pharmacopoeia","first-page":"61","author":"Zheng","year":"2005"},{"key":"10.1016\/j.vph.2014.04.007_bb0060","first-page":"234","article-title":"36 cases analysis for Sjogren's symptom by Chinese medicine","volume":"9","author":"Liu","year":"2005","journal-title":"Chi Clin Rehabil"},{"key":"10.1016\/j.vph.2014.04.007_bb0065","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00253-011-3829-7","article-title":"Review of research on Dendrobium, a prized folk medicine","volume":"93","author":"Ng","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vph.2014.04.007_bb0070","first-page":"150","volume":"vol. I","author":"Chinese Pharmacopeia Commission","year":"2010"},{"key":"10.1016\/j.vph.2014.04.007_bb0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.5483\/BMBRep.2007.40.5.670","article-title":"Antioxidant and anti-hyperglycemic activity of polysaccharide isolated from Dendrobium chrysotoxum Lindl","volume":"40","author":"Zhao","year":"2007","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.vph.2014.04.007_bb0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijbiomac.2013.12.024","article-title":"Comparison of hypoglycemic and antioxidative effects of polysaccharides from four different Dendrobium species","volume":"64","author":"Pan","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vph.2014.04.007_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.chroma.2005.12.012","article-title":"Simultaneous determination of phenols (bibenzyl, phenanthrene, and fluorenone) in Dendrobium species by high-performance liquid chromatography with diode array detection","volume":"1104","author":"Yang","year":"2006","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vph.2014.04.007_bb0090","series-title":"Experimental study of Fufang XueshuanTong on intervention of retinopathy in diabetic rats","first-page":"13","author":"Huang","year":"2006"},{"key":"10.1016\/j.vph.2014.04.007_bb0095","first-page":"573","article-title":"Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor","volume":"6","author":"Gong","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.vph.2014.04.007_bb0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/0022-3859.97176","article-title":"Current trends in the pharmacotherapy of diabetic retinopathy","volume":"58","author":"Kumar","year":"2012","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.vph.2014.04.007_bb0105","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.04.007_bb0110","first-page":"239","article-title":"The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy","volume":"6","author":"Aldebasi","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.vph.2014.04.007_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874364101307010004","article-title":"Diabetic retinopathy and VEGF","volume":"7","author":"Gupta","year":"2013","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.vph.2014.04.007_bb0120","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2014.04.007_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bjophthalmol-2011-300674","article-title":"Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review","volume":"96","author":"Zechmeister-Koss","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.vph.2014.04.007_bb0130","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2337\/db12-1744","article-title":"Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy","volume":"62","author":"Titchenell","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2014.04.007_bb0135","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/OPTH.S36443","article-title":"Critical appraisal of ranibizumab in the treatment of diabetic macular edema","volume":"7","author":"Stewart","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.vph.2014.04.007_bb0140","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.04.007_bb0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/13543784.2012.681043","article-title":"Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9","volume":"21","author":"Kowluru","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.vph.2014.04.007_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12177-012-9091-0","article-title":"Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy","volume":"5","author":"Mohammad","year":"2012","journal-title":"J Ocul Biol Dis Inform"},{"key":"10.1016\/j.vph.2014.04.007_bb0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5114\/aoms.2010.14258","article-title":"Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy","volume":"6","author":"Klysik","year":"2010","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.vph.2014.04.007_bb0160","first-page":"181","article-title":"Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats","volume":"2","author":"Bhatt","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.vph.2014.04.007_bb0165","first-page":"1114","article-title":"Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy","volume":"14","author":"Beranek","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.vph.2014.04.007_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Simo","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.vph.2014.04.007_bb0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/157339910793360815","article-title":"Angiogenic growth factors and their inhibitors in diabetic retinopathy","volume":"6","author":"Praidou","year":"2010","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.vph.2014.04.007_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","article-title":"NF-kappa B: ten years after","volume":"87","author":"Baeuerle","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.vph.2014.04.007_bb0185","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jlb.66.6.876","article-title":"Regulation of intercellular adhesion molecule-1 (CD54) gene expression","volume":"66","author":"Roebuck","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vph.2014.04.007_bb0190","doi-asserted-by":"crossref","first-page":"629452","DOI":"10.1155\/2012\/629452","article-title":"Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy","volume":"2012","author":"Gologorsky","year":"2012","journal-title":"Mediators Inflamm"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:33:06Z","timestamp":1649007186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189114000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1537189114000871"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2014.04.007","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}